Skip to main content
Top
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Research article

Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members

Authors: Velisha Ann Perumal-Pillay, Fatima Suleman

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

The South African (SA) public health system has employed an Essential Medicines List (EML) with Standard Treatment Guidelines (STGs) in the public sector since 1996. To date no studies have reported on the process of selection of essential medicines for SA EMLs and how this may have changed over time. This study reports on the decision making process for the selection of essential medicines for SA EMLs, over the years, as described by various members of the National Essential Medicines List Committee (NEMLC) and their task teams.

Methods

Qualitative in-depth interviews, guided by an interview questionnaire, were conducted with 11 members of the SA NEMLC and their task teams (both past and present members) during the period January – April 2015. Interviews were recorded and transcribed verbatim. Transcripts were then coded by the first author and verified by the second author before being reconciled and input into NVIVO, a qualitative software, to facilitate analysis of the data.

Results

The interviews conducted suggest that the NEMLC process of medicine selection has been refined over the years. This together with the EML review process is now essentially predominantly an evidence based process where quality, safety and efficacy of a medicine is considered first followed by cost considerations which includes pharmacoeconomic evaluations, and pricing of medicines.

Conclusions

This is the first study in SA to report on how decisions are taken to include or exclude medicines on SA national EMLs and provides insight into the SA EML medicine selection, review and monitoring processes over time. The results show that the NEMLC has undergone tremendous transformation over the years. Whilst the membership of the committee largely remains unchanged, the committee has developed its policies and processes over the years. However there is still a need to strengthen the monitoring and evaluation aspects of the SA EML policy process.
Literature
2.
go back to reference Coovadia S, Jewkes R, Barron P, Sanders D, McIntyre D. Health in South Africa 1, the health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009. doi:10.1016/S0140-6736(09)60951-X. Coovadia S, Jewkes R, Barron P, Sanders D, McIntyre D. Health in South Africa 1, the health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009. doi:10.​1016/​S0140-6736(09)60951-X.
3.
go back to reference Primary Health Care Standard Treatment Guidelines and Essential Drugs List 1996. South Africa: The National Department of Health; 1996. Primary Health Care Standard Treatment Guidelines and Essential Drugs List 1996. South Africa: The National Department of Health; 1996.
5.
go back to reference Laing R, Waning B, Gray A, Ford N. ‘t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723–29.CrossRefPubMed Laing R, Waning B, Gray A, Ford N. ‘t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723–29.CrossRefPubMed
11.
go back to reference Ventola CL. An interview series with members of the ASHP expert panel on formulary management. P&T. 2010;35(1):623–31. Ventola CL. An interview series with members of the ASHP expert panel on formulary management. P&T. 2010;35(1):623–31.
14.
go back to reference Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, Bowman M. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69(3):548–56.PubMed Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, Bowman M. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69(3):548–56.PubMed
16.
go back to reference Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, ‘t Hoen EFM, Wagner AK, Yadav P, Reich MR. Essential medicines for universal health coverage. The Lancet. 2016. http://dx.doi.org/10.1016/S0140-6736(16)31599-9. Accessed 16 Nov 2016. Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, ‘t Hoen EFM, Wagner AK, Yadav P, Reich MR. Essential medicines for universal health coverage. The Lancet. 2016. http://​dx.​doi.​org/​10.​1016/​S0140-6736(16)31599-9. Accessed 16 Nov 2016.
19.
go back to reference Lopert R. Evidence-based decision-making within Australia’s pharmaceutical benefits scheme. Issue Brief (Commonw Fund). 2009;60:1–13. Lopert R. Evidence-based decision-making within Australia’s pharmaceutical benefits scheme. Issue Brief (Commonw Fund). 2009;60:1–13.
20.
go back to reference Botswana Essential Drugs List (1st Ed) 2005. Ministry of Health (2005). Republic of Botswana. Botswana Essential Drugs List (1st Ed) 2005. Ministry of Health (2005). Republic of Botswana.
22.
go back to reference Roughead EE, Lhazeen K, Socialine E, Bahri S, Park BJ, Holloway K. Monitoring medicines use to support national medicines policy development and implementation in the Asia pacific region. WHO South-east Asia J Public Health. 2013;2(2):113–7.CrossRef Roughead EE, Lhazeen K, Socialine E, Bahri S, Park BJ, Holloway K. Monitoring medicines use to support national medicines policy development and implementation in the Asia pacific region. WHO South-east Asia J Public Health. 2013;2(2):113–7.CrossRef
25.
go back to reference Brudon P, Rainhorn BP, Reich MR. Indicators for monitoring national drug policies. 2nd ed. Geneva: World Health Organization; 2000. Brudon P, Rainhorn BP, Reich MR. Indicators for monitoring national drug policies. 2nd ed. Geneva: World Health Organization; 2000.
Metadata
Title
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Authors
Velisha Ann Perumal-Pillay
Fatima Suleman
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1946-9

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue